CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus

Affiliations

Case Reports

Dimitrios Mougiakakos et al. N Engl J Med. 2021.

. 2021 Aug 5;385(6):567-569.

doi: 10.1056/NEJMc2107725.

¹ Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany georg.schett@uk-erlangen.de.

No abstract available

Comment in

CAR T cells induce remission in a patient with refractory SLE.
Onuora S. Onuora S. Nat Rev Rheumatol. 2021 Oct;17(10):579. doi: 10.1038/s41584-021-00691-2. Nat Rev Rheumatol. 2021. PMID: 34471267 No abstract available.
More on CD19-CAR T Cells in Systemic Lupus Erythematosus.
Konig MF, Paul S. Konig MF, et al. N Engl J Med. 2021 Nov 4;385(19):e67. doi: 10.1056/NEJMc2114593. N Engl J Med. 2021. PMID: 34731550 No abstract available.
CAR-T cell therapy: new hope for systemic lupus erythematosus patients.
Jin X, Han Y, Wang JQ, Lu L. Jin X, et al. Cell Mol Immunol. 2021 Dec;18(12):2581-2582. doi: 10.1038/s41423-021-00787-5. Epub 2021 Nov 4. Cell Mol Immunol. 2021. PMID: 34737415 Free PMC article. No abstract available.